Botox and filler product safety in Turkey: TİTCK, CE and FDA
Medical reviewer: Dr. Hamza Gemici ·
Botox and filler product safety in Turkey should be evaluated through lawful supply, traceable product records, TİTCK context, CE or FDA status where applicable, correct indication and physician-led use. FDA approval is not a blanket statement for every product, country or indication; the product name, active ingredient and intended use should be specified. Patients may ask to know the product name, lot number, expiry date, anatomical purpose and available alternatives. For hyaluronic acid fillers, clinics should also be prepared for complication management, including access to hyaluronidase. Product safety supports safer care, but it does not guarantee an outcome.
1. TİTCK context in Turkey
TİTCK is the Turkish Medicines and Medical Devices Agency. In practical patient terms, it relates to lawful supply, product registration and traceability within Turkey. Patients should avoid unclear-source products, clinic-outside injections and situations where box or lot information cannot be documented.
2. CE marking
CE marking is part of the European medical device regulatory framework. Many hyaluronic acid dermal fillers are discussed in CE context. CE status does not mean every patient or every area is suitable; product choice still depends on anatomy, tissue plane and risk profile.
3. FDA approval
FDA approval applies to specific products and indications within the United States regulatory system. A brand may have some FDA-approved indications while other uses or markets differ. Medical communication should avoid vague “FDA approved” claims unless product and indication are clear.
4. Questions patients can ask
Useful questions include: What product is being used? What is the lot number? What is the expiry date? Why is this product selected for this area? What are the alternatives? What aftercare instructions apply? For HA fillers, is hyaluronidase available if urgent management is needed?
5. Dr. Hamza Gemici’s product approach
At the Ataşehir clinic, product choice is based on anatomy, indication, tissue quality, safety profile and physician assessment rather than trend-based selection. Address: Atatürk Mah. Turgut Özal Bulv. Gardenya 4-2 No:6-A D:2, Ataşehir 34758 Istanbul, Turkey. Phone and WhatsApp: +90 532 344 82 16.
Frequently asked questions
Are TİTCK and FDA the same?
No. TİTCK is Turkey’s regulatory authority context; FDA is the United States regulatory system. Product status should be interpreted by country, product and indication.
Can I ask for the lot number?
Yes. Lot number and expiry date support traceability and should be part of responsible product documentation.
Does product safety guarantee results?
No. Product traceability is one safety factor. Outcomes also depend on anatomy, indication, dose, technique, aftercare and individual response.
Why is hyaluronidase important?
Hyaluronidase can dissolve hyaluronic acid filler and is important for selected correction or urgent complication management.
What is a red flag?
Unclear-source products, no box or lot information, non-clinical settings, pressure discounts and no follow-up plan are red flags.
We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.